Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/11/14  and contains information from public web pages.

Dr. Wieslaw Marek Cholody

Wrong Dr. Wieslaw Marek Cholody?
 
Background

Employment History

Education

  • PhD , Medicinal Chemistry
    Technical University of Gdansk
Web References
Actokine Therapeutics
www.actokine.com, 11 Feb 2014 [cached]
Vice President of Chemistry- Marek Cholody, PhD
...
Vice President of Chemistry - Marek Cholody, PhD Dr. Cholody has been involved in drug discovery for over 20 years. Upon completion of his PhD in Medicinal Chemistry at the Technical University of Gdansk, Poland, he joined the faculty of the Department of Pharmaceutical Technology and Biochemistry where he conducted research focused on the design and synthesis of small molecule anticancer agents. This led to the discovery of a new class of drugs - the imidazoacridones. The leading compound in this class, C-1311, is presently in Phase 2 clinical trials under the name Symadex. In 1993, Dr. Cholody joined the Molecular Aspects of Drug Design team at the National Cancer Institute, where he discovered and developed two new classes of potential anticancer and anti-AIDS agents. In 2001, he joined Avalon Pharmaceuticals as a Research Group Leader in the Medicinal Chemistry Department where he was instrumental in establishing and validating Avalon's gene expression-based drug discovery platform. His work at Avalon led to AVN316 which was nominated as clinical candidate in company's beta-catenin program. Dr. Cholody is an expert in DNA-interacting anticancer agents. He has published 26 papers and has 9 issued patents on anticancer drugs.
Actokine Therapeutics
www.actokine.com, 20 May 2013 [cached]
Vice President of Chemistry- W. Marek Cholody, PhD Vice President of Biologics - Green Zhang, PhD
...
Vice President of Chemistry - W. Marek Cholody, PhD Dr. Cholody has been involved in drug discovery for over 20 years. Upon completion of his PhD in Medicinal Chemistry at the Technical University of Gdansk, Poland, he joined the faculty of the Department of Pharmaceutical Technology and Biochemistry where he conducted research focused on the design and synthesis of small molecule anticancer agents. This led to the discovery of a new class of drugs - the imidazoacridones. The leading compound in this class, C-1311, is presently in Phase 2 clinical trials under the name Symadex. In 1993, Dr. Cholody joined the Molecular Aspects of Drug Design team at the National Cancer Institute, where he discovered and developed two new classes of potential anticancer and anti-AIDS agents. In 2001, he joined Avalon Pharmaceuticals as a Research Group Leader in the Medicinal Chemistry Department where he was instrumental in establishing and validating Avalon's gene expression-based drug discovery platform. His work at Avalon led to AVN316 which was nominated as clinical candidate in company's beta-catenin program. Dr. Cholody is an expert in DNA-interacting anticancer agents. He has published 26 papers and has 9 issued patents on anticancer drugs.
International Drug Discovery Science and Technology (IDDST) 2008
www.iddst.com [cached]
Dr. Wieslaw Marek Cholody, Research Group Leader, Avalon Pharmaceuticals, Inc, USA
Dr. Wieslaw Marek Cholody, ...
www.iddst.com [cached]
Dr. Wieslaw Marek Cholody, Research Group Leader, Avalon Pharmaceuticals, Inc, USA
Other People with the name "Cholody":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.